By Joey BerlinSouthern Bureau ChiefBy the end of the year, it appears that generic versions of one of the top 10 drugs prescribed in workers’ compensation cases will be on the market.Celebrex manufacturer Pfizer settled part of a twisty legal dispute last month when it reportedly reached an agreement with two manufacturers, Teva Pharmaceuticals and Actavis, to market generic versions of Celebrex as soon as this December. The Food and Drug Administration then granted Teva exclusive rights for a generic Celebrex – prompting suits against the FDA from Actavis and other generic manufac...
Comments